Full-Time

Key Account Vice President

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

Healthcare technology using AI for patient outcomes

Compensation Overview

$200k - $250k/yr

+ Incentive Compensation + Restricted Stock Units

Expert

Company Historically Provides H1B Sponsorship

Remote in USA + 1 more

More locations: Chicago, IL, USA

Remote roles are open to individuals in unincorporated Los Angeles.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Sales
Requirements
  • Minimum of 10+ years in business development, sales, or account management in the Life Sciences sector (Pharma/Biotech), with a focus on strategic accounts.
  • At least 5+ years of experience working with companies servicing Life Sciences organizations in R&D or Real-World Data.
  • Proven track record of establishing credibility as a trusted advisor and negotiating large, complex multi-year agreements.
  • Strong understanding of molecular data, AI applications, and their role in drug discovery and development.
Responsibilities
  • Develop and drive the overall account strategy, collaborating with scientific and business operations teams to achieve revenue and partnership goals.
  • Act as the executive account owner to ensure the success of the partnership, meeting regularly with senior-level counterparts to align on objectives, KPIs, and OKRs.
  • Build and maintain executive and R&D relationships, driving engagement through Tempus leadership involvement and CXO strategy.
  • Become an expert in the partner’s strategy, pipeline, and portfolio to proactively identify opportunities to leverage the Tempus platform for innovation.
  • Meet and exceed revenue goals across all Tempus product lines while ensuring alignment with strategic account objectives.
  • Identify and secure new business opportunities and projects, negotiating and managing large, multi-year contracts.
  • Align and lead a cross-functional team of Product Specialists, Alliance Managers, Translational Researchers, and Commercial Operations to deliver value to the client efficiently.
  • Provide guidance to the KAD and Project Manager to ensure seamless execution of initiatives and projects.
  • Partner with clients to develop impactful case studies showcasing the Tempus platform’s role in advancing precision medicine.
  • Contribute feedback to Life Sciences leadership regarding client responses, suggestions, and market trends.
  • Track and report progress against defined strategic objectives and revenue goals, regularly updating Tempus leadership.
  • Travel approximately 40% domestically and internationally to support client relationships and account strategy.
  • Perform other duties as assigned.
Desired Qualifications
  • Advanced degree preferred (MBA, PhD, or equivalent in science or business discipline).

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Deep 6 AI expands Tempus' data network and precision medicine capabilities.
  • Partnership with Stemline Therapeutics strengthens Tempus' position in personalized cancer treatment.
  • Collaboration with Artera expands Tempus' reach in oncology diagnostics.

What critics are saying

  • Integration challenges with Deep 6 AI may lead to operational inefficiencies.
  • $560 million debt increases financial leverage, posing a risk if growth falters.
  • Regulatory hurdles may arise in expanding DNA profiling beyond cancer with Illumina.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids in personalized cancer treatment through advanced data insights.
  • Tempus collaborates with leading biotech firms to enhance drug development processes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
SDBN
Apr 15th, 2025
Illumina teams up with Tempus to expand DNA profiling beyond cancer

Illumina teams up with Tempus to expand DNA profiling beyond cancer.

Life Care News
Mar 30th, 2025
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting

Tempus exhibits 4 abstracts at the 2025 American College of Cardiology Annual Meeting.

Tempus
Mar 12th, 2025
Tempus Announces Acquisition of Deep 6 AI | Tempus AI

Deep 6 is integrated with over 750 provider site locations spanning more than 30 million patients, which will materially add to Tempus’ existing network CHICAGO --(BUSINESS WIRE)--Mar. 11, 2025-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision

TipRanks
Mar 12th, 2025
Tempus AI (TEM) Strengthens Precision Medicine with Deep 6 AI Deal, Cathie Wood Buys the Dip

Tempus AI has acquired Deep 6 AI to expand its reach and enhance offerings in precision medicine.

Business Wire
Feb 25th, 2025
Ares Management Upsizes Tempus Debt Facilities to $560 Million

Combined with $260 million of capital provided in 2022 and 2023, Ares Credit funds have provided Tempus a total debt package of approximately $560 million.